ABSTRACT About Women's Health Diagnostics Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have led to new product development user-friendly diagnostic instruments for laboratories and physician offices, as well as home-care settings. Manufacturers are increasingly shifting toward shortened analyzer product cycles with value-added features such as portability of instruments to stay ahead in the market. Technavio’s analysts forecast the global women's health diagnostics market to grow at a CAGR of 6.58% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global women's health diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from biomarkers is considered. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Women's Health Diagnostics Market 2017-2021, has been prepared... Research Beam Model: Research Beam Product ID: 1592535 3500 USD New
Global Women's Health Diagnostics Market 2017-2021
 
 

Global Women's Health Diagnostics Market 2017-2021

  • Category : Healthcare
  • Published On : May   2017
  • Pages : 70
  • Publisher : Technavio
 
 
 
ABSTRACT
About Women's Health Diagnostics

Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have led to new product development user-friendly diagnostic instruments for laboratories and physician offices, as well as home-care settings. Manufacturers are increasingly shifting toward shortened analyzer product cycles with value-added features such as portability of instruments to stay ahead in the market.

Technavio’s analysts forecast the global women's health diagnostics market to grow at a CAGR of 6.58% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global women's health diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from biomarkers is considered.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Women's Health Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abbott Laboratories
• F. Hoffmann-La Roche
• Hologic
• Siemens Healthineers

Other prominent vendors
• ACON Laboratories
• Alere
• Becton Dickinson (BD)
• bioMérieux
• Bio-Rad Laboratories
• Carl Zeiss Meditec
• Cepheid
• Danaher
• Illumina
• Mindray
• Natera
• Sysmex
• Thermo Fisher Scientific
• Urit Medical

Market driver
• Reimbursements for human papillomavirus (HPV) tests.
• For a full, detailed list, view our report

Market challenge
• High cost of mammography equipment.
• For a full, detailed list, view our report

Market trend
• Increased use of rapid diagnostic testing.
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by application
• Cancer
• UTIs
• Gynecology and fertility
• Osteoporosis
PART 07: Market segmentation by end-user
• Hospitals
• Clinical diagnostic laboratories
• ASCs
• Home-care settings
PART 08: Geographical segmentation
• Women’s health diagnostics market in Americas
• Women’s health diagnostics market in EMEA
• Women’s health diagnostics market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Increased use of rapid diagnostic testing
• Increasing M&As
• Increasing demand for home-care monitoring equipment
PART 12: Vendor landscape
• Competitive scenario
PART 13: Key vendor analysis
• Abbott Laboratories
• F. Hoffmann-La Roche
• Hologic
• Siemens Healthineers
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global women's health diagnostics market 2016-2021
Exhibit 02: Global women's health diagnostics market 2016-2021: Overview
Exhibit 03: Global women's health diagnostics market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global women's health diagnostics market by application, 2016 (%)
Exhibit 06: Global women's health cancer testing market 2016-2021: Overview
Exhibit 07: Breast cancer: Key takeaways
Exhibit 08: Mammography screening for breast cancer cases (% of women screened)
Exhibit 09: Cervical cancer: Key takeaways
Exhibit 10: Ovarian cancer: Key takeaways
Exhibit 11: Global women's health cancer testing market 2016-2021 ($ billions)
Exhibit 12: Global women's health UTI testing market 2016-2021: Overview
Exhibit 13: Global women's health UTI testing market 2016-2021 ($ billions)
Exhibit 14: UTI testing market: Key takeaways
Exhibit 15: Global women's health gynecology and fertility testing market 2016-2021: Overview
Exhibit 16: Global women's health gynecology and fertility testing market 2016-2021 ($ billions)
Exhibit 17: Gynecology and fertility testing market: Key takeaways
Exhibit 18: Global women's health osteoporosis testing market 2016-2021: Overview
Exhibit 19: Global women's health osteoporosis testing market 2016-2021 ($ billions)
Exhibit 20: Global women's health osteoporosis testing market- Key takeaways
Exhibit 21: Global women's health diagnostics market by end-user (2016)
Exhibit 22: Hospitals in global women's health diagnostic market
Exhibit 23: Clinical diagnostic laboratories in global women's health diagnostic market
Exhibit 24: ASCs in global women's health diagnostic market
Exhibit 25: Home-care settings in global women's health diagnostics market
Exhibit 26: Buying criteria analysis: Global women's health diagnostics market by end-users
Exhibit 27: Smoking rate in women aged 15+ year, 2014 (%)
Exhibit 28: Global women's health diagnostics market by geography 2016 (%)
Exhibit 29: Women's health diagnostics market in Americas 2016-2021: Overview
Exhibit 30: Women's health diagnostic market in Americas 2016-2021 ($ billions)
Exhibit 31: Women's health diagnostics market in EMEA 2016-2021: Overview
Exhibit 32: Women's health diagnostic market in EMEA 2016-2021 ($ billions)
Exhibit 33: Women's health diagnostics market in APAC 2016-2021: Overview
Exhibit 34: Women's health diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 35: Death of women due to breast cancer (%) 2015
Exhibit 36: Survival rate of cervical cancer cases 2013
Exhibit 37: Number of mammography units installed per 1,000,000 inhabitants
Exhibit 38: Advanced catheter portfolio
Exhibit 39: M&As
Exhibit 40: Competitive structure analysis of global women's health diagnostics market 2016
Exhibit 41: Competitive landscape analysis of global women's health diagnostics market 2016
Exhibit 42: Strategic success factors of companies in global women's health diagnostics market
Exhibit 43: Abbott Laboratories: Key highlights
Exhibit 44: Abbott Laboratories: Strength assessment
Exhibit 45: Abbott Laboratories: Strategy assessment
Exhibit 46: Abbott Laboratories: Opportunity assessment
Exhibit 47: F. Hoffmann-La Roche: Key highlights
Exhibit 48: F. Hoffmann-La Roche: Strength assessment
Exhibit 49: F. Hoffmann-La Roche: Strategy assessment
Exhibit 50: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 51: Hologic: Key highlights
Exhibit 52: Hologic: Strategy assessment
Exhibit 53: Hologic: Strategy assessment
Exhibit 54: Hologic: Opportunity assessment
Exhibit 55: Siemens Healthineers: Key highlights
Exhibit 56: Siemens Healthineers: Strength assessment
Exhibit 57: Siemens Healthineers: Strategy assessment
Exhibit 58: Siemens Healthineers: Opportunity assessment
Exhibit 59: Other prominent vendors

PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT